1. HBW Insight
  2. >>Wellness
  3. >>Policy & Regulation
  4. >>Regulation

Food Additive Group Says US FDA NDIN Draft Guidance Leaves Master File ‘Necessity Unclear’

 
• By Malcolm Spicer

International Food Additives Council suggests master file system will be redundant to submitting NDINs required for some dietary ingredients. IFAC also asks FDA to clarify whether the history of a substance’s use in food “is at the strain level or species level.”

• Source: Shutterstock

The International Food Additives Council asks the US Food and Drug Administration to clarify when a master file rather than a new dietary ingredient notification should be submitted to the agency and whether an ingredient’s history of use “is at the strain level or species level.”

The global association representing manufacturers and end-users of food ingredients, including dietary ingredients for supplements, suggests a master file system...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

AESGP Annual Meeting: Harmonizing EU VMS Max Levels Could Cost Sector Over €200m

 
• By David Ridley

Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By Sue Sutter

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.

House Appropriators’ $3.2Bn For FDA In FY 2026 Includes More Non-User Fee Funds Than Requested

 
• By Sue Sutter and Derrick Gingery

A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.